UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Discovery of Ledipasvir (GS-5885): A Potent, Once-Daily Oral NS5A Inhibitor for the Treatment of Hepatitis C Virus Infection

Journal of medicinal chemistry, 2014-03, Vol.57 (5), p.2033-2046

2014

Volltextzugriff (PDF)

Wogonin inhibits in vitro herpes simplex virus type 1 and 2 infection by modulating cellular NF-κB and MAPK pathways

BMC microbiology, 2020-07, Vol.20 (1), p.227-227, Article 227

2020

Volltextzugriff (PDF)

Complement C3 gene polymorphisms are associated with lipid levels, but not the risk of coronary artery disease: a case-control study

Lipids in health and disease, 2019-12, Vol.18 (1), p.217-217, Article 217

2019

Volltextzugriff (PDF)

Cobicistat (GS-9350): A Potent and Selective Inhibitor of Human CYP3A as a Novel Pharmacoenhancer

ACS medicinal chemistry letters, 2010-08, Vol.1 (5), p.209-213

2010

Volltextzugriff (PDF)

Relationship between warfarin dosage and international normalized ratio: a dose–response analysis and evaluation based on multicenter data

European journal of clinical pharmacology, 2019-06, Vol.75 (6), p.785-794

2019

Volltextzugriff (PDF)

Interrelationships between ALOX5AP polymorphisms, serum leukotriene B4 level and risk of acute coronary syndrome

PloS one, 2014-09, Vol.9 (9), p.e106596-e106596

2014

Volltextzugriff (PDF)

Preclinical Characterization of GS-9669, a Thumb Site II Inhibitor of the Hepatitis C Virus NS5B Polymerase

Antimicrobial Agents and Chemotherapy, 2013-02, Vol.57 (2), p.804-810

2013

Volltextzugriff (PDF)

miR-1271 promotes non-small-cell lung cancer cell proliferation and invasion via targeting HOXA5

Biochemical and biophysical research communications, 2015-03, Vol.458 (3), p.714-719

2015

Volltextzugriff (PDF)

Correction to Discovery of Ledipasvir (GS-5885): A Potent, Once-Daily Oral NS5A Inhibitor for the Treatment of Hepatitis C Virus Infection

Journal of medicinal chemistry, 2016-08, Vol.59 (16), p.7696-7696

2016

Volltextzugriff (PDF)

A novel and efficient synthesis of chiral C2-symmetric 1,4-diamines

Tetrahedron letters, 2009-02, Vol.50 (5), p.552-554

2009

Volltextzugriff (PDF)

Mutations in Multiple Domains of Gag Drive the Emergence of In Vitro Resistance to the Phosphonate-Containing HIV-1 Protease Inhibitor GS-8374

Journal of Virology, 2013-01, Vol.87 (1), p.454-463

2013

Volltextzugriff (PDF)

In Vitro Characterization of GS-8374, a Novel Phosphonate-Containing Inhibitor of HIV-1 Protease with a Favorable Resistance Profile

Antimicrobial Agents and Chemotherapy, 2011-04, Vol.55 (4), p.1366-1376

2011

Volltextzugriff (PDF)

Structure–activity relationships of diamine inhibitors of cytochrome P450 (CYP) 3A as novel pharmacoenhancers, part I: Core region

Bioorganic & medicinal chemistry letters, 2014-02, Vol.24 (3), p.989-994

2014

Volltextzugriff (PDF)

Design, synthesis and characterizations of prodrugs of brexanolone

Bioorganic & medicinal chemistry letters, 2023-06, Vol.90, p.129344-129344, Article 129344

2023

Volltextzugriff (PDF)

Retraction notice to “miR-1271 promotes non-small-cell lung cancer cell proliferation and invasion via targeting HOXA5” [Biochem. Biophys. Res. Commun. 458/3 (2015) 714–719]

Biochemical and biophysical research communications, 2019-08, Vol.515 (4), p.729-729

2019

Volltextzugriff (PDF)

GS-8374, a Novel HIV Protease Inhibitor, Does Not Alter Glucose Homeostasis in Cultured Adipocytes or in a Healthy-Rodent Model System

Antimicrobial Agents and Chemotherapy, 2011-04, Vol.55 (4), p.1377-1382

2011

Volltextzugriff (PDF)

N1-Heterocyclic pyrimidinediones as non-nucleoside inhibitors of HIV-1 reverse transcriptase

Bioorganic & medicinal chemistry letters, 2010-03, Vol.20 (5), p.1585-1588

2010

Volltextzugriff (PDF)

SAR studies on dihydropyrimidinone antibiotics

Bioorganic & medicinal chemistry letters, 2011-03, Vol.21 (6), p.1670-1674

2011

Volltextzugriff (PDF)

N1-Alkyl pyrimidinediones as non-nucleoside inhibitors of HIV-1 reverse transcriptase

Bioorganic & medicinal chemistry letters, 2010-03, Vol.20 (5), p.1589-1592

2010

Volltextzugriff (PDF)

RETRACTED: miR-1271 promotes non-small-cell lung cancer cell proliferation and invasion via targeting HOXA5

Biochemical and biophysical research communications, 2015-03, Vol.458 (3), p.714-719

2015

Volltextzugriff (PDF)

Preclinical characterization of a non-peptidomimetic HIV protease inhibitor with improved metabolic stability

Antimicrobial agents and chemotherapy, 2024-04, Vol.68 (4), p.e0137323-e0137323

2024

Volltextzugriff (PDF)

Synthesis of novel HIV-1 protease inhibitors via diastereoselective Henry reaction with nitrocyclopropane

Tetrahedron letters, 2017-03, Vol.58 (12), p.1123-1126

2017

Volltextzugriff (PDF)

Wogonin inhibits in vitro herpes simplex virus type 1 and 2 infection by modulating cellular NF-ÎºB and MAPK pathways

BMC microbiology, 2020-07, Vol.20 (1)

2020

Volltextzugriff (PDF)

miR-1179 promotes cell invasion through SLIT2/ROBO1 axis in esophageal squamous cell carcinoma

International journal of clinical and experimental pathology, 2015, Vol.8 (1), p.319-327

2015

Volltextzugriff (PDF)

1283. Safety, Tolerability, and Pharmacokinetics of BRII-778, A Modified-Release Oral Formulation of Rilpivirine in Healthy Adult Subjects

Open forum infectious diseases, 2022-12, Vol.9 (Supplement_2)

2022

Volltextzugriff (PDF)

1 – 25 von 334

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(291)
Mit Volltextzugriff
(308)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Discovery of Ledipasvir (GS-5885): A Potent, Once-Daily Oral NS5A Inhibitor for the Treatment of Hepatitis C Virus Infection

Wogonin inhibits in vitro herpes simplex virus type 1 and 2 infection by modulating cellular NF-κB and MAPK pathways

Complement C3 gene polymorphisms are associated with lipid levels, but not the risk of coronary artery disease: a case-control study

Cobicistat (GS-9350): A Potent and Selective Inhibitor of Human CYP3A as a Novel Pharmacoenhancer

Relationship between warfarin dosage and international normalized ratio: a dose–response analysis and evaluation based on multicenter data

Interrelationships between ALOX5AP polymorphisms, serum leukotriene B4 level and risk of acute coronary syndrome

Preclinical Characterization of GS-9669, a Thumb Site II Inhibitor of the Hepatitis C Virus NS5B Polymerase

miR-1271 promotes non-small-cell lung cancer cell proliferation and invasion via targeting HOXA5

Correction to Discovery of Ledipasvir (GS-5885): A Potent, Once-Daily Oral NS5A Inhibitor for the Treatment of Hepatitis C Virus Infection

A novel and efficient synthesis of chiral C2-symmetric 1,4-diamines

Mutations in Multiple Domains of Gag Drive the Emergence of In Vitro Resistance to the Phosphonate-Containing HIV-1 Protease Inhibitor GS-8374

In Vitro Characterization of GS-8374, a Novel Phosphonate-Containing Inhibitor of HIV-1 Protease with a Favorable Resistance Profile

Structure–activity relationships of diamine inhibitors of cytochrome P450 (CYP) 3A as novel pharmacoenhancers, part I: Core region

Design, synthesis and characterizations of prodrugs of brexanolone

Retraction notice to “miR-1271 promotes non-small-cell lung cancer cell proliferation and invasion via targeting HOXA5” [Biochem. Biophys. Res. Commun. 458/3 (2015) 714–719]

GS-8374, a Novel HIV Protease Inhibitor, Does Not Alter Glucose Homeostasis in Cultured Adipocytes or in a Healthy-Rodent Model System

N1-Heterocyclic pyrimidinediones as non-nucleoside inhibitors of HIV-1 reverse transcriptase

SAR studies on dihydropyrimidinone antibiotics

N1-Alkyl pyrimidinediones as non-nucleoside inhibitors of HIV-1 reverse transcriptase

RETRACTED: miR-1271 promotes non-small-cell lung cancer cell proliferation and invasion via targeting HOXA5

Preclinical characterization of a non-peptidomimetic HIV protease inhibitor with improved metabolic stability

Synthesis of novel HIV-1 protease inhibitors via diastereoselective Henry reaction with nitrocyclopropane

Wogonin inhibits in vitro herpes simplex virus type 1 and 2 infection by modulating cellular NF-ÎºB and MAPK pathways

miR-1179 promotes cell invasion through SLIT2/ROBO1 axis in esophageal squamous cell carcinoma

1283. Safety, Tolerability, and Pharmacokinetics of BRII-778, A Modified-Release Oral Formulation of Rilpivirine in Healthy Adult Subjects

Suchergebnisse filtern